AMIDEBIO

amidebio-logo

AmideBio, LLC, a biotechnology company, focuses on the development, production, and commercialization of peptide research reagents and clinical products for research and development, clinical, and therapeutic marketplaces.

#People #Website #More

AMIDEBIO

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2009-01-01

Address:
Louisville, Colorado, United States

Country:
United States

Website Url:
http://www.AmideBio.com

Total Employee:
1+

Status:
Active

Contact:
303 604 0296

Email Addresses:
[email protected]

Total Funding:
2.59 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Sitelinks Search Box



Current Advisors List

david-brunel_image

David Brunel Chairman @ AmideBio
Board_member
2001-04-01

Current Employees Featured

not_available_image

Michael H. B Stowell
Michael H. B Stowell Founder & CTO @ AmideBio
Founder & CTO

not_available_image

Mikhail Misha Plam
Mikhail Misha Plam President & CEO @ AmideBio
President & CEO
2009-01-01

Founder


not_available_image

Michael H. B Stowell

not_available_image

Mikhail Misha Plam

Official Site Inspections

http://www.AmideBio.com

  • Host name: 143.198.146.38
  • IP address: 143.198.146.38
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "AmideBio"

Home | Amidebio | Novel Peptides Targeting Metabolic โ€ฆ

AmideBio is leveraging its in-silico design and proprietary peptide synthesis capabilities to develop a pipeline of unique peptide drug candidates targeting some of the biggest therapeutic challenges for metabolic disease. In addition, โ€ฆSee details»

AmideBio - Crunchbase Company Profile & Funding

AmideBio, LLC, a biotechnology company, focuses on the development, production, and commercialization of peptide research reagents and clinical products for research and โ€ฆSee details»

About | Amidebio | Novel Peptides Targeting Metabolic Disease

AmideBio was founded in 2009 to commercialize the proprietary BioPure platform technology to deliver difficult-to-manufacture, ultrapure peptides to the biopharmaceutical industry and โ€ฆSee details»

amidebio.com Reviews: Is this site a scam or legit?

Organization Proxy Protection LLC . Owner Proxy Protection LLC . Address 417 Associated Rd #327 C/O amidebio.com . State CA . Country UNITED STATES . Country Code US . ...See details»

AmideBio 2025 Company Profile: Valuation, Funding & Investors

AmideBio General Information Description. Operator of a biotechnology company intended to develop peptide therapeutics for metabolic disease The company's platform develops and โ€ฆSee details»

AmideBio, LLC Company Profile | Louisville, CO | Competitors ...

Find company research, competitor information, contact details & financial data for AmideBio, LLC of Louisville, CO. Get the latest business insights from Dun & Bradstreet.See details»

AmideBio - Org Chart, Teams, Culture & Jobs - The Org

View AmideBio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

AmideBio - Funding, Financials, Valuation & Investors - Crunchbase

Organization. AmideBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 8. obfuscated. ... AmideBio โ€ฆSee details»

AmideBio Company Profile - Office Locations, Competitors ... - Craft

AmideBio has 5 employees across 2 locations and $2.59 m in total funding,. See insights on AmideBio including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

AmideBio - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 20, 2025 AmideBio is a biotechnology company focused on providing recombinant peptide research and clinical products for a diverse array of disease research and disease targets. It โ€ฆSee details»

AmideBio - Contacts, Employees, Board Members, Advisors

AmideBio develops and commercializes peptide research reagents and clinical products for clinical and therapeutic marketplaces. ... Experience the new Crunchbase, powered by AI . โ€ฆSee details»

AmideBio - Products, Competitors, Financials, Employees, โ€ฆ

About AmideBio. AmideBio focuses on the development of novel peptides for the treatment of metabolic diseases within the biotechnology sector. The company leverages in-silico design โ€ฆSee details»

AmideBio - Overview, News & Similar companies | ZoomInfo.com

Aug 20, 2020 AmideBio, LLC, a privately held biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) Office of Orphan Products Development โ€ฆSee details»

AmideBio, LLC | Venture Partners at CU Boulder - University of โ€ฆ

AmideBio discovers and develops novel peptides for the treatment of metabolic diseases. In addition, AmideBio leverages its proprietary BioPureโ„ข peptide manufacturing technology to โ€ฆSee details»

AmideBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase

AmideBio develops and commercializes peptide research reagents and clinical products for clinical and therapeutic marketplaces. New. Resources. Advanced Search. Start Free Trial . โ€ฆSee details»

Novel Peptides Targeting Metabolic Disease - Amidebio

AmideBio has built a catalog of peptides using its BioPure process ensuring unequaled purity and lack of contaminating side and by-products. While other manufacturers strive to achieve 97% โ€ฆSee details»

Boulderโ€™s AmideBio wins SBIR grant for diabetes treatment research

Sep 16, 2024 Small Business Innovation Research grant funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) โ€œwill allow AmideBio to develop a dual โ€ฆSee details»

News | Amidebio | Novel Peptides Targeting Metabolic Disease

Sep 3, 2018 BOULDER, CO, March 8, 2021 โ€“ AmideBio, LLC, a privately-held biopharmaceutical company, announced today that it has received $300,000 in funding โ€ฆSee details»

If Anthropic Succeeds, a Nation of Benevolent AI Geniuses Could โ€ฆ

Mar 28, 2025 The brother goes on vision quests. The sister is a former English major. Together, they defected from OpenAI, started Anthropic, and built (they say) AIโ€™s most upstanding โ€ฆSee details»

AmideBio Awarded SBIR Phase IIB Grant to Support Pre-Clinical ...

BOULDER, CO, October 4th, 2022 โ€“ AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $2.69M in funding through a Phase IIB Small โ€ฆSee details»